| Mrs Amanda Krekling, | |
|
6580 S 46th St, Franklin, WI 53132-8153 | |
| (414) 421-0276 | |
| Not Available |
| Full Name | Mrs Amanda Krekling |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 6580 S 46th St, Franklin, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073155073 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 189534 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amanda Krekling, 2704 James Blvd, Racine, WI 53403-3248 Ph: (262) 497-2098 | Mrs Amanda Krekling, 6580 S 46th St, Franklin, WI 53132-8153 Ph: (414) 421-0276 |
News Archive
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
Physicians may be able to make early decisions on the best treatment for breast cancer, thanks to research published in Breast Cancer Research today.
Whitehead Institute scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within the cellular organelles known as mitochondria, often referred to as the "powerhouses of the cell."
Cancer becomes life threatening when tumor cells start leaving their primary site. They travel through the lymph and blood streams to other tissues where they grow into metastases. This transition to malignancy is associated with characteristic changes in the cancer cells. The activity of several genes is reprogrammed and, thus, the production of proteins anchoring cells to a tissue is reduced. On the other hand, the amount of surface markers which make a cancer cell mobile increases.
New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated that, in the contemporary era, gender is not an independent mortality predictor following PCI according to the study now available in Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.
› Verified 2 days ago
Mrs. Lisa Anne Voegeli, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9340 S 47th St, Franklin, WI 53132 Phone: 414-421-6800 | |
Lauren R Burch, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7466 S 46th St, Franklin, WI 53132 Phone: 414-331-0249 | |
Irina Korolkov, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9301 S Cobblestone Way Unit G, Franklin, WI 53132 Phone: 414-736-7475 | |
Helen Olson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6580 S 46th St, Franklin, WI 53132 Phone: 414-421-0276 | |
Mrs. Dawn Marie Porter, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7103 Jordan Ct, Franklin, WI 53132 Phone: 414-425-2538 | |
Judith A Mackay, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9383 S Springhill Ln, Franklin, WI 53132 Phone: 414-423-0852 |